Immunic, Inc. (IMUX)Healthcare | Biotechnology | New York, United States | NasdaqCM
1.00 USD
After hours: 1.00 Short-term: ★★★★☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 6:34 p.m. EDT
IMUX is currently a high-volatility narrative play driven entirely by the massive $400M private placement and a shift to commercial execution, rather than fundamental profitability. While the company remains unprofitable with negative book value (a classic 'speculative' long-term trap), the immediate catalyst is undeniable. The stock has surged from penny stock territory, and options flow confirms traders are betting on a continuation of this rally, ignoring the lack of dividends and negative earnings. It is a momentum trade for the short term, but the valuation remains disconnected from financial reality, making it a fragile hold for long-term investors waiting for commercial proof. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.394494 |
| AutoARIMA | 0.409069 |
| AutoETS | 0.409244 |
| AutoTheta | 0.474683 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 18.88 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.119 |
| Excess Kurtosis | -1.21 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 130,464,824 |
| Forward P/E | -3.00 |
| Beta | 1.37 |
| Website | https://imux.com |
As of April 18, 2026, 6:34 p.m. EDT: Speculators are heavily positioned for volatility and upside potential in the near term. Near-term (April 17) calls show significant Open Interest at the 2.00 and 5.00 strikes (approx. 3k OI each) compared to minimal Put OI, suggesting a directional bet on a rally rather than a hedge. The Extremely high OTM Call OI relative to volume in the short expirations indicates momentum chasing. Conversely, July puts show notable OI at the 1.50 strike, but the dominance of far OTM calls in the weekly/monthly expirations points to an aggressive bullish stance on catalyst realization (likely the $400M placement execution).
| Attribute | Value |
|---|---|
| 52 Week Change | 0.011122346 |
| Address1 | 1,200 Avenue of the Americas |
| Address2 | Suite 200 |
| All Time High | 1,408.0 |
| All Time Low | 0.506 |
| Ask | 1.05 |
| Ask Size | 4 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 2,797,830 |
| Average Daily Volume3 Month | 3,669,237 |
| Average Volume | 3,669,237 |
| Average Volume10Days | 2,797,830 |
| Beta | 1.372 |
| Bid | 0.9602 |
| Bid Size | 4 |
| Board Risk | 7 |
| Book Value | -0.055 |
| City | New York |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.0 |
| Current Ratio | 0.747 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.0599 |
| Day Low | 0.97 |
| Display Name | Immunic |
| Dividend Date | 1,555,286,400 |
| Earnings Call Timestamp End | 1,730,984,400 |
| Earnings Call Timestamp Start | 1,730,984,400 |
| Earnings Timestamp | 1,772,112,600 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda | -103,060,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.121 |
| Enterprise Value | 115,558,824 |
| Eps Current Year | -0.42 |
| Eps Forward | -0.33375 |
| Eps Trailing Twelve Months | -0.62 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.07186 |
| Fifty Day Average Change | -0.071859956 |
| Fifty Day Average Change Percent | -0.0670423 |
| Fifty Two Week Change Percent | 1.1122346 |
| Fifty Two Week High | 1.51 |
| Fifty Two Week High Change | -0.51 |
| Fifty Two Week High Change Percent | -0.33774835 |
| Fifty Two Week Low | 0.506 |
| Fifty Two Week Low Change | 0.49400002 |
| Fifty Two Week Low Change Percent | 0.9762847 |
| Fifty Two Week Range | 0.506 - 1.51 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,397,741,400,000 |
| Float Shares | 121,075,272 |
| Forward Eps | -0.33375 |
| Forward P E | -2.9962547 |
| Free Cashflow | -50,656,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 92 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01016 |
| Held Percent Institutions | 0.5564 |
| Implied Shares Outstanding | 130,464,825 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,555,286,400 |
| Last Split Factor | 1:40 |
| Long Business Summary | Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York. |
| Long Name | Immunic, Inc. |
| Market | us_market |
| Market Cap | 130,464,824 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_403013221 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -97,172,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 130,464,825 |
| Number Of Analyst Opinions | 7 |
| Open | 1.0 |
| Operating Cashflow | -85,806,000 |
| Operating Margins | 0.0 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 332 255 9818 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.0 |
| Post Market Time | 1,776,470,372 |
| Previous Close | 1.0 |
| Price Eps Current Year | -2.3809524 |
| Price Hint | 4 |
| Price To Book | -18.181818 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.64 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.22222 |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 1.0599 |
| Regular Market Day Low | 0.97 |
| Regular Market Day Range | 0.97 - 1.0599 |
| Regular Market Open | 1.0 |
| Regular Market Previous Close | 1.0 |
| Regular Market Price | 1.0 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 3,298,743 |
| Return On Assets | -1.9876 |
| Return On Equity | -16.53147 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 130,464,825 |
| Shares Percent Shares Out | 0.0686 |
| Shares Short | 8,954,740 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,579,660 |
| Short Name | Immunic, Inc. |
| Short Percent Of Float | 0.0766 |
| Short Ratio | 2.9 |
| Source Interval | 15 |
| State | NY |
| Symbol | IMUX |
| Target High Price | 10.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 5.42857 |
| Target Median Price | 5.0 |
| Total Cash | 15,483,000 |
| Total Cash Per Share | 0.119 |
| Total Debt | 577,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.62 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.85554 |
| Two Hundred Day Average Change | 0.14446002 |
| Two Hundred Day Average Change Percent | 0.16885245 |
| Type Disp | Equity |
| Volume | 3,298,743 |
| Website | https://imux.com |
| Zip | 10,036 |